Literature DB >> 28962191

Diagnostic value and prognostic evaluation of dynamic video-electroencephalogram monitoring in children with epilepsy.

Xiaobo Wu1, Ying Su1, Wei Liu1, Xiaoyu Jia1, Yanling Zhang1, Xinyang Zhang1, Guilan Wang1.   

Abstract

The diagnostic and prognostic value of dynamic video-electroencephalogram (V-EEG) monitoring in children with epilepsy were investigated. From February 2014 to February 2016, in total 200 children with epilepsy were selected during their stay in the First Hospital of Qinghuangdao and were randomly allocated to a dynamic and a conventional V-EEG monitoring group (n=100). The detection rate of epileptiform discharges in the two groups was evaluated. The V-EEG monitoring index was used to select treatment methods for patients with epilepsy. After 3 months, the patients were rechecked. Disease features and incidence of epilepsy were recorded. There were no significant differences in the course of disease, seizure frequency and age between the two groups (P>0.05). The detection rate of epileptiform discharges in the dynamic V-EEG was significantly higher than in the routine monitoring group (P<0.01). The accuracy and specificity of monitoring in the V-EEG were significantly higher than in the routine monitoring group (P<0.01). Seizure frequency and number of epilepsy attacks in patients in the V-EEG group were significantly lower than in the routine monitoring group (P<0.01). Dynamic V-EEG can improve epilepsy detection rate. The high accuracy and specificity of dynamic V-EEG suggest that it may be of great clinical value in the diagnosis and prognosis of epilepsy.

Entities:  

Keywords:  dynamic video-electroencephalogram; epilepsy; prognostic evaluation

Year:  2017        PMID: 28962191      PMCID: PMC5609305          DOI: 10.3892/etm.2017.4822

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

One of the common diseases of the nervous system, epilepsy is a paroxysmal disease that is mainly caused by the abnormal discharge of brain neurons or synchronization activities (1–3). Epilepsy can occur in various forms and onset is often uncertain, though it occurs mainly in children. These factors may complicate clinical diagnosis and abnormal neuronal discharge recorded by electroencephalogram (EEG) is often used in the diagnosis (4–6). Dynamic EEG is a commonly used tool for the detection of epilepsy, but it has the disadvantages of high false-positive rate and poor synchronization accuracy (7,8). Dynamic EEG combined with video observation can be used for the long-term simultaneous monitoring of the performance of patients with epilepsy and can be used to diagnose the onset of epilepsy (9,10). The aim of this study is to investigate the differences between dynamic V-EEG and conventional EEG in the diagnosis of epilepsy and identify which method has better accuracy, efficiency and specificity for diagnosis and prognosis.

Materials and methods

Subjects

Patients involved in this study were all selected from February 2014 to 2016 while receiving neurological treatment in the First Hospital of Qinghuangdao. Included patients were all found to have different degrees of epilepsy-like symptoms by clinical examination and were all subsequently diagnosed with epilepsy. Consumptive diseases and other diseases that can cause EEG changes were ruled out in all included patients. Legal guardians of the included children signed the informed consent form and detailed clinical data were recorded for all patients.

Grouping

The 200 patients were randomly allocated to either the dynamic V-EEG or the conventional monitoring group. The age, sex, weight, number of seizures and course of disease, as well as other clinical and pathological data were subjected to statistical analysis. According to their assigned monitoring group, patients were subjected to 24 h of dynamic V-EEG or conventional EEG monitoring.

Methods

The electrodes of the dynamic V-EEG recorder (Vidy dynamic video EEG recording box; Biologics Co., London, UK) were set according to the international 10/20 system and reference electrodes were placed at the ear position on both sides. The electrodes were fixed in a double-layer elastic cap. Patients were subjected to 24 h of dynamic EEG monitoring and clinical manifestations and EEG changes were recorded. The experiment was induced by blinking and hyperventilation. Epilepsy symptoms were recorded as clinical manifestations and epilepsy-like EEG for 72 h (if during 24 h of monitoring, a patient exhibited epilepsy-like EEG, monitoring was continued for 72 h). EEGs in the routine monitoring group were recorded using a dynamic EEG monitoring system (Weisi Technology Co., Jiangsu, China); all other steps were the same as those of the dynamic V-EEG monitoring group.

Intervention treatment

Epilepsy seizure types detected by both dynamic V-EEG and conventional EEG monitoring were classified according to the criteria established by the International League Against Epilepsy (ILAE). Patients were given appropriate drugs for routine treatment. Patients in the dynamic V-EEG and routine monitoring group were subjected to the same drug treatment. After 3 months, the patients were rechecked. Disease features and incidence of epilepsy attacks were recorded. The prognosis was evaluated.

Evaluation method

Evaluation of epileptic symptoms

According to the classification criteria for seizures and symptoms of epilepsy established by ILAE, symptoms of epilepsy were divided into partial, spastic, typical absence, atypical absence, tonic-clonic, atonic, myoclonic and complex seizures. The numbers of patients experiencing each type in both groups were recorded.

Prognostic evaluation

Comprehensive evaluation was carried out according to the EEG before treatment and prognosis of patients after treatment. If the patient showed good indicators and good prognosis after treatment then the symptom was judged as false negative (FN); if indicators were good and prognosis was poor, true negative (TN); if both indicators and prognosis were poor, true positive (TP); if indicators were not good but prognosis was good after treatment, false positive (FP). The accuracy (accuracy = (TP+TN)/number of patients × 100%), error rate (error rate = FP/number of patients × 100%) and specificity (specificity = TN/(TN+FP) × 100%) were calculated.

Statistical analysis

All the data were analyzed by SPSS 18.0 software (SPSS Inc., Chicago, IL, USA). The data were expressed as mean ± standard deviation (SD). Student's t-test and variance analysis were used to compare the two independent samples. Countable data were tested using χ2 test or non-parametric rank sum test. A P<0.05 was considered to indicate a statistically significant difference.

Results

General information and clinicopathological features of patients

Of the 200 patients, 109 were male and 91 were female. The mean age was 8.28±3.56 years. The course of disease and seizure frequency of the patients in both the dynamic V-EEG and conventional monitoring groups are shown in Table I. There were no significant differences in age, sex, course of disease or seizure frequency between the two groups (P>0.05). The different types of epilepsy symptoms are shown in Table II. There were no significant differences in epilepsy types between the two groups (P>0.05).
Table I.

General information and clinicopathological features of patients.

Sex

GroupsPatientsMean age (years)Male (n)Female (n)Mean duration of disease (years)Seizure frequency (per week)
Dynamic V-EEG1008.53±3.8654463.27±2.522.18±0.86
Conventional1008.09±3.2755453.47±2.182.32±0.78
χ20.030.08
P-value>0.05>0.05>0.05>0.05

V-EEG, video-electroencephalogram.

Table II.

Classification of epilepsy types in the two groups.

GroupsPartial seizures (n)Spastic seizures (n)Typical absence seizures (n)Atypical absence seizures (n)Tonic-clonic seizures (n)Atonic seizures (n)Myoclonic seizures (n)Complex seizures (n)
Dynamic V-EEG5815315819
Conventional55164241027
P-value>0.05>0.05>0.05>0.05>0.05>0.05>0.05>0.05

V-EEG, video-electroencephalogram.

The detection of epileptic discharge

The epilepsy detection rate in the two groups is shown in Fig. 1. The detection rate in the dynamic V-EEG monitoring group was significantly higher than in the conventional monitoring group (93 vs. 76 cases, P<0.05).
Figure 1.

The epilepsy detection rate in the two groups over 72 h. The detection rate in the dynamic V-EEG monitoring group was significantly higher than in the conventional monitoring group (*P<0.05). V-EEG, video-electroencephalogram.

The epilepsy detection rate at different time points

The rate of detection by dynamic V-EEG monitoring and conventional monitoring was analyzed and compared at different time points (Fig. 2). The detection rates by dynamic V-EEG monitoring at 1, 2, 3, and 4 h were 43, 57, 69, and 76%, respectively, all significantly higher than by conventional monitoring at the corresponding time point (P<0.01).
Figure 2.

The epilepsy detection rate at different time points in each group. The detection rates by dynamic V-EEG monitoring at 1, 2, 3 and 4 h were all higher than those by conventional monitoring at the corresponding time point (**P<0.01). V-EEG, video-electroencephalogram.

Comparison of post-treatment seizures

Patients with the same type of epilepsy in both groups were subjected to the same drug treatment. After 3 months of treatment, the frequency and duration of each seizure were recorded and analyzed (Table III). The results showed that the frequency and duration of each seizure in patients of dynamic V-EEG monitoring group were both significantly lower than those in patients of conventional monitoring group (P<0.01 and P<0.05, respectively).
Table III.

Comparison of post-treatment seizures (mean ± SD).

GroupsNo. of seizures (n)Duration of each seizure (min)
Dynamic V-EEG7.7±3.6415±6.91
Conventional12.64±8321±7.48
P-value<0.01<0.05

V-EEG, video-electroencephalogram.

Prognostic evaluation of epilepsy

Patients in both groups were rechecked 3 months after treatment and compared with the EEG data before treatment. The patients were divided into FN, TN, FP and TP, and the specificity, accuracy and error rate were calculated to evaluate prognosis (Table IV). The prognostic accuracy and specificity in the dynamic V-EEG were significantly higher than those in the conventional monitoring group, while the error rate in the dynamic V-EEG was significantly lower than in the conventional monitoring group (P<0.01).
Table IV.

Prognostic evaluation of epilepsy in the two groups.

GroupsnTN (n)FN (n)TP (n)FP (n)AccuracyError rateSpecificity
Dynamic V-EEG9337  5401182.8%11.8%77.1%
Conventional762513211860.5%23.7%58.1%
P-value<0.01<0.01<0.01

V-EEG, video-electroencephalogram.

Discussion

As a common form of epilepsy, pediatric epilepsy has recently attracted more attention in clinical practice (11). Due to the uncertainty of the time of onset and frequency of seizures, as well as inconsistent clinical manifestations, pediatric epilepsy has become a refractory disease (12–14). The pathogenesis of pediatric epilepsy is still unclear; previous studies have shown that pediatric epilepsy is related to abnormal brain development, genetic disease, brain infections, trauma and cerebrovascular diseases (15–17). At present, EEG is widely used in the detection of pediatric epilepsy. As a device to detect brain waves, EEG can effectively detect abnormal discharge of brain neurons and record whole brain waves at any time, including during exercise and sleep. Dynamic V-EEG can record both EEG and patients' clinical manifestations, which can then be combined for the diagnosis and classification of epilepsy (18). Our study mainly discussed the application value of dynamic V-EEG in the diagnosis and prognostic evaluation of pediatric epilepsy. Conventional dynamic EEG monitoring was used as the control group. We found that dynamic EEG monitoring combined with video observation to monitor both EEG changes and the clinical manifestations of epilepsy can significantly increase the accuracy of the detection of epilepsy. In addition, dynamic V-EEG monitoring had the advantages of high accuracy, high specificity and low error rate. The most reliable basis for the diagnosis of epilepsy is EEG-clinical synchronous seizures and dynamic V-EEG can monitor both the EEG and clinical manifestations and use the combination of these to make a diagnosis. Dynamic V-EEG and conventional EEG were used to classify epilepsy types for appropriate treatment. We found that the prognosis was significantly better in the dynamic V-EEG than that in conventional monitoring group. In addition, the frequency and duration of each seizure in patients in the dynamic V-EEG were both significantly lower than those in patients in the conventional monitoring group. The results showed that dynamic V-EEG monitoring is more accurate for the diagnosis and classification of epilepsy than conventional dynamic EEG monitoring. As a digital EEG method derived from dynamic EEG, dynamic V-EEG not only can accurately localize the epileptiform discharges during playback analysis but also has great value in the classification of epilepsy (19,20). In conclusion, dynamic V-EEG has several advantages over conventional EEG. Dynamic V-EEG can significantly increase the accuracy of diagnosis, so as to ensure appropriate symptomatic treatment. Therefore, dynamic V-EEG has great clinical value in the diagnosis and prognosis of epilepsy and will likely become one of the most commonly used and most reliable tools in the treatment of epilepsy.
  20 in total

1.  Stigma of people with epilepsy in China: views of health professionals, teachers, employers, and community leaders.

Authors:  Rong-Rong Yang; Wen-Zhi Wang; Dee Snape; Gong Chen; Lei Zhang; Jian-Zhong Wu; Gus A Baker; Xiao-Ying Zheng; Ann Jacoby
Journal:  Epilepsy Behav       Date:  2011-05-24       Impact factor: 2.937

2.  Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care.

Authors:  Anne T Berg; Tobias Loddenkemper; Christine B Baca
Journal:  Epilepsia       Date:  2013-12-06       Impact factor: 5.864

3.  Familial risk of epilepsy: a population-based study.

Authors:  Anna L Peljto; Christie Barker-Cummings; Vincent M Vasoli; Cynthia L Leibson; W Allen Hauser; Jeffrey R Buchhalter; Ruth Ottman
Journal:  Brain       Date:  2014-01-26       Impact factor: 13.501

Review 4.  Priorities in pediatric epilepsy research: improving children's futures today.

Authors:  Anne T Berg; Christine B Baca; Tobias Loddenkemper; Barbara G Vickrey; Dennis Dlugos
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

Review 5.  Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy.

Authors:  Jorge G Burneo; Nathalie Jette; William Theodore; Charles Begley; Karen Parko; David J Thurman; Samuel Wiebe
Journal:  Epilepsia       Date:  2009-09-03       Impact factor: 5.864

6.  Disparities in surgery among patients with intractable epilepsy in a universal health system.

Authors:  Jorge G Burneo; Salimah Z Shariff; Kuan Liu; Sean Leonard; Gustavo Saposnik; Amit X Garg
Journal:  Neurology       Date:  2015-12-07       Impact factor: 9.910

Review 7.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Tracking psychosocial health in adults with epilepsy--estimates from the 2010 National Health Interview Survey.

Authors:  R Kobau; W Cui; N Kadima; M M Zack; M Sajatovic; K Kaiboriboon; B Jobst
Journal:  Epilepsy Behav       Date:  2014-10-07       Impact factor: 2.937

9.  Epilepsy care and mental health care for people with epilepsy: California Health Interview Survey, 2005.

Authors:  Alexander W Thompson; Rosemarie Kobau; Royce Park; David Grant
Journal:  Prev Chronic Dis       Date:  2012-02-23       Impact factor: 2.830

10.  Factors affecting reorganisation of memory encoding networks in temporal lobe epilepsy.

Authors:  M K Sidhu; J Stretton; G P Winston; M Symms; P J Thompson; M J Koepp; J S Duncan
Journal:  Epilepsy Res       Date:  2014-11-11       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.